Towards precision pain medicine for pain after cancer: the Cancer Pain Phenotyping Network multidisciplinary international guidelines for pain phenotyping using nociplastic pain criteria

Autor: Jo Nijs, Astrid Lahousse, César Fernández-de-las-Peñas, Pascal Madeleine, Christel Fontaine, Tomohiko Nishigami, Christine Desmedt, Marian Vanhoeij, Kenza Mostaqim, Antonio I. Cuesta-Vargas, Eleni Kapreli, Paraskevi Bilika, Andrea Polli, Laurence Leysen, Ömer Elma, Eva Roose, Emma Rheel, Sevilay Tümkaya Yılmaz, Liesbet De Baets, Eva Huysmans, Ali Turk, İsmail Saraçoğlu

Publikováno v: Nijs, J, Lahousse, A, Fernández-de-Las-Peñas, C, Madeleine, P, Fontaine, C, Nishigami, T, Desmedt, C, Vanhoeij, M, Mostaqim, K, Cuesta-Vargas, A I, Kapreli, E, Bilika, P, Polli, A, Leysen, L, Elma, Ö, Roose, E, Rheel, E, Yılmaz, S T, De Baets, L, Huysmans, E, Turk, A & Saraçoğlu, İ 2023, ' Towards precision pain medicine for pain after cancer : the Cancer Pain Phenotyping Network multidisciplinary international guidelines for pain phenotyping using nociplastic pain criteria ', British Journal of Anaesthesia, vol. 130, no. 5, pp. 611-621 . https://doi.org/10.1016/j.bja.2022.12.013

Pain after cancer remains underestimated and undertreated. Precision medicine is a recent concept that refers to the ability to classify patients into subgroups that differ in their susceptibility to, biology, or prognosis of a particular disease, or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0777e5e4c1b95f09d1c1a98407550ab
https://doi.org/10.1016/j.bja.2022.12.013